Exocrine pancreatic insufficiency (EPI) is one of the possible mechanisms of fat maldigestion following gastric surgery, together with reduced food intake, loss of gastric reservoir, small bowel bacterial overgrowth and rapid small bowel transit. Oral pancreatic enzyme replacement therapy (PERT) is the mainstay of treatment for EPI. The efficacy and safety of pancreatic enzyme substitution in patients following gastric resection remains unclear. This review article summarizes relevant studies addressing PERT after gastric resection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.dld.2017.10.025 | DOI Listing |
Publication Analysis
Top Keywords
pancreatic enzyme
12
gastric resection
12
enzyme replacement
8
replacement therapy
8
small bowel
8
gastric
5
pancreatic
4
therapy gastric
4
resection update
4
update exocrine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!